Product Information
LYVISPAH 10 MG GRANULE PACKET is a brand product labeled by Amneal Pharmaceuticals LLC, priced at $3.4541 per EA under NDC 64896007709. Its NADAC has been published 37 times since Mar 19, 2025.
FDA first approved this application on Nov 22, 2021.
The High Outlier badge above means this manufacturer's average price in the baclofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
64896007709
Classification
Brand
Dosage Form
GRANULE
Route
ORAL
Effective Date
3/19/2025
Active Ingredients
BACLOFENApproval Type
New Drug (NDA)
FDA Application
NDA215422FDA Approved
11/22/2021
On Market Since
6/1/2023
Pharmacological Classes
Price Statistics
The NADAC for LYVISPAH 10 MG GRANULE PACKET has been published 37 times since Mar 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4541 per EA |
|---|---|
| All-time high | $3.4541 (Nov 26, 2025) |
| All-time low | $3.4541 (Mar 19, 2025) |
| 52-week high | $3.4541 |
| 52-week low | $3.4541 |
| Median price | $3.4541 |
| Average price | $3.4540 |
| Largest weekly change | 0.0% (Mar 26, 2025) |
| Weeks tracked | 37 |
| Tracking since | Mar 19, 2025 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Nov 26, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the baclofen market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LYVISPAH 10 MG GRANULE PACKET?
The current National Average Drug Acquisition Cost (NADAC) for LYVISPAH 10 MG GRANULE PACKET, manufactured by Amneal Pharmaceuticals LLC, is $3.4541 per EA (NDC 64896007709), effective Nov 26, 2025.
How has the price of LYVISPAH 10 MG GRANULE PACKET changed over time?
Over the history we have for it, the NADAC for LYVISPAH 10 MG GRANULE PACKET has held within roughly two percent of its current level. It has been tracked across 37 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for LYVISPAH 10 MG GRANULE PACKET?
Since Mar 19, 2025, the NADAC for LYVISPAH 10 MG GRANULE PACKET has ranged from a low of $3.4541 (Mar 19, 2025) to a high of $3.4541 (Nov 26, 2025), with a median of $3.4541 per EA.
Are there cheaper alternatives to LYVISPAH 10 MG GRANULE PACKET?
No other NADAC-published product currently shares the active ingredient and strength of LYVISPAH 10 MG GRANULE PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LYVISPAH 10 MG GRANULE PACKET?
LYVISPAH 10 MG GRANULE PACKET (NDC 64896007709) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a brand product.